We found that uptake of vesicles from stroma correlated with increased protection against imatinib-driven apoptosis (Fig. 5a), visible as significantly lower percentage of Annexin V-staining in DiD+ CML cells, compared with CML cells negative for vesicles (DiD−). Here, ANXA5 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.